0001562180-22-000350.txt : 20220107
0001562180-22-000350.hdr.sgml : 20220107
20220107211639
ACCESSION NUMBER: 0001562180-22-000350
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220106
FILED AS OF DATE: 20220107
DATE AS OF CHANGE: 20220107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Coric Vlad
CENTRAL INDEX KEY: 0001704317
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 22519444
MAIL ADDRESS:
STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
STREET 2: 234 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-01-06
false
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001704317
Coric Vlad
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
true
true
false
false
Chief Executive Officer
Common Shares
2022-01-06
4
M
false
12500.00
0.00
A
38072.00
D
Common Shares
2022-01-06
4
F
false
5854.00
123.86
D
32218.00
D
Common Shares
2022-01-07
4
M
false
10000.00
0.00
A
42218.00
D
Common Shares
2022-01-07
4
F
false
4634.00
128.87
D
37584.00
D
Common Shares
19130.00
I
By 401(K) Plan
Common Shares
100000.00
I
By The Vladimir Coric GRAT - 2019
Common Shares
331000.00
I
By The Vladimir Coric Marital Trust
Common Shares
470000.00
I
By: The Vladimir Coric Family Trust
Restricted Share Unit Award
2022-01-06
4
M
false
12500.00
0.00
D
Common Shares
12500.00
25000.00
D
Stock Option (Right to Buy)
128.87
2022-01-07
4
A
false
70000.00
0.00
A
2032-01-07
Common Shares
70000.00
70000.00
D
Restricted Share Unit Award
2022-01-07
4
A
false
40000.00
0.00
A
Common Shares
40000.00
40000.00
D
Restricted Share Unit Award
2022-01-07
4
M
false
10000.00
0.00
D
Common Shares
10000.00
30000.00
D
No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
This balance includes 288 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2021.
Each restricted share unit represents the contingent right to receive one common share of the Issuer.
The reporting person was granted 50,000 restricted share units on January 6, 2021, vesting in four equal installments on January 6, 2021, 2022, 2023 and 2024, subject to the reporting person's continued service with the Issuer at each vesting date.
Not applicable.
The shares underlying this option vest in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service with the Issuer at each vesting date.
The reporting person was granted 40,000 restricted share units on January 7, 2022, vesting in four equal installments on January 7, 2022, 2023, 2024 and 2025, subject to the reporting person's continued service with the Issuer at each vesting date.
Exhibit List: Exhibit 24: Power of attorney
/s/ George Clark, Attorney-in-Fact
2022-01-07
EX-24
2
vcoricpoa21.txt
POA2021
POWER OF
ATTORNEY
Know all by these presents, that the undersigned hereby
constitutes and appoints each of Matthew Buten, George Clark
and Douglas Gray, or either of them signing singly, and with
full power of substitution, the undersigned's true and lawful
attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on
the undersigned's behalf, and submit to the U.S.
Securities and Exchange Commission (the "SEC") any
documents necessary or appropriate to obtain codes
and passwords enabling the undersigned to make
electronic filings with the SEC of reports
required by Section 16(a) of the Securities
Exchange Act of 1934 or any rule or regulation of
the SEC;
(2) execute for and on behalf of the undersigned Forms
3, 4, and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the rules
thereunder;
(3) do and perform any and all acts for and on behalf
of the undersigned which may be necessary or
desirable to complete and execute any such Form 3,
4, or 5, complete and execute any amendment or
amendments thereto, and timely file such form with
the SEC and any stock exchange or similar
authority; and
(4) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion
of such attorney-in-fact, may be of benefit to, in
the best interest of, or legally required by, the
undersigned, it being understood that the
documents executed by such attorney-in-fact on
behalf of the undersigned pursuant to this Power of
Attorney shall be in such form and shall contain
such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-
fact full power and authority to do and perform any and every
act and thing whatsoever requisite, necessary, or proper to
be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with
full power of substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully
do or cause to be done by virtue of this power of attorney
and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not
assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to file
Forms 3, 4, and 5 with respect to the undersigned's holdings
of and transactions in securities issued by Biohaven
Pharmaceutical Holding Company Ltd., unless earlier revoked
by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this
Power of Attorney to be executed as of this 21st day of
December, 2021.
/s/ Vlad Coric
Signature
Vlad
Coric,
M.D. Print Name